342 related articles for article (PubMed ID: 33593354)
21. PA2G4 promotes the metastasis of hepatocellular carcinoma by stabilizing FYN mRNA in a YTHDF2-dependent manner.
Sun S; Liu Y; Zhou M; Wen J; Xue L; Han S; Liang J; Wang Y; Wei Y; Yu J; Long X; Chen X; Liang H; Huang Z; Zhang B
Cell Biosci; 2022 May; 12(1):55. PubMed ID: 35526051
[TBL] [Abstract][Full Text] [Related]
22. YTHDF2 inhibit the tumorigenicity of endometrial cancer via downregulating the expression of IRS1 methylated with m
Hong L; Pu X; Gan H; Weng L; Zheng Q
J Cancer; 2021; 12(13):3809-3818. PubMed ID: 34093789
[TBL] [Abstract][Full Text] [Related]
23. Understanding YTHDF2-mediated mRNA degradation by m6A-BERT-Deg.
Zhang TH; Jo S; Zhang M; Wang K; Gao SJ; Huang Y
Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38622358
[TBL] [Abstract][Full Text] [Related]
24. The RNA m6A Reader YTHDF2 Maintains Oncogene Expression and Is a Targetable Dependency in Glioblastoma Stem Cells.
Dixit D; Prager BC; Gimple RC; Poh HX; Wang Y; Wu Q; Qiu Z; Kidwell RL; Kim LJY; Xie Q; Vitting-Seerup K; Bhargava S; Dong Z; Jiang L; Zhu Z; Hamerlik P; Jaffrey SR; Zhao JC; Wang X; Rich JN
Cancer Discov; 2021 Feb; 11(2):480-499. PubMed ID: 33023892
[TBL] [Abstract][Full Text] [Related]
25. Hypoxia-mediated YTHDF2 overexpression promotes lung squamous cell carcinoma progression by activation of the mTOR/AKT axis.
Xu P; Hu K; Zhang P; Sun ZG; Zhang N
Cancer Cell Int; 2022 Jan; 22(1):13. PubMed ID: 34996459
[TBL] [Abstract][Full Text] [Related]
26. N6-methyladenosine reader YTHDF family in biological processes: Structures, roles, and mechanisms.
Chen L; Gao Y; Xu S; Yuan J; Wang M; Li T; Gong J
Front Immunol; 2023; 14():1162607. PubMed ID: 36999016
[TBL] [Abstract][Full Text] [Related]
27. N6-methyladenosine-dependent regulation of messenger RNA stability.
Wang X; Lu Z; Gomez A; Hon GC; Yue Y; Han D; Fu Y; Parisien M; Dai Q; Jia G; Ren B; Pan T; He C
Nature; 2014 Jan; 505(7481):117-20. PubMed ID: 24284625
[TBL] [Abstract][Full Text] [Related]
28. YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma.
Hou J; Zhang H; Liu J; Zhao Z; Wang J; Lu Z; Hu B; Zhou J; Zhao Z; Feng M; Zhang H; Shen B; Huang X; Sun B; Smyth MJ; He C; Xia Q
Mol Cancer; 2019 Nov; 18(1):163. PubMed ID: 31735169
[TBL] [Abstract][Full Text] [Related]
29. YTHDF2 Suppresses Notch Signaling through Post-transcriptional Regulation on Notch1.
Lee B; Lee S; Shim J
Int J Biol Sci; 2021; 17(14):3776-3785. PubMed ID: 34671198
[TBL] [Abstract][Full Text] [Related]
30. YTHDF2 is a Potential Biomarker and Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma.
Su G; Liu T; Han X; Sun H; Che W; Hu K; Xiao J; Li Y; Liu Y; Li W; Mei H
Front Pharmacol; 2021; 12():709548. PubMed ID: 34512342
[TBL] [Abstract][Full Text] [Related]
31. YTHDF2 Inhibits the Migration and Invasion of Lung Adenocarcinoma by Negatively Regulating the FAM83D-TGFβ1-SMAD2/3 Pathway.
Zhao T; Wang M; Zhao X; Weng S; Qian K; Shi K; Gu Y; Ying W; Qian X; Zhang Y
Front Oncol; 2022; 12():763341. PubMed ID: 35186724
[TBL] [Abstract][Full Text] [Related]
32. Expression and Clinical Significance of the m6A RNA-Binding Proteins
Luo Q; Guo Y; Xiao Q; Fu B; Zhang L; Guo Y; Huang Z; Li J
Front Med (Lausanne); 2022; 9():922219. PubMed ID: 35755020
[TBL] [Abstract][Full Text] [Related]
33. YTH domain family 2 promotes lung cancer cell growth by facilitating 6-phosphogluconate dehydrogenase mRNA translation.
Sheng H; Li Z; Su S; Sun W; Zhang X; Li L; Li J; Liu S; Lu B; Zhang S; Shan C
Carcinogenesis; 2020 Jul; 41(5):541-550. PubMed ID: 31504235
[TBL] [Abstract][Full Text] [Related]
34. Molecular Mechanisms Driving mRNA Degradation by m
Lee Y; Choe J; Park OH; Kim YK
Trends Genet; 2020 Mar; 36(3):177-188. PubMed ID: 31964509
[TBL] [Abstract][Full Text] [Related]
35. The biological function of m6A demethylase ALKBH5 and its role in human disease.
Wang J; Wang J; Gu Q; Ma Y; Yang Y; Zhu J; Zhang Q
Cancer Cell Int; 2020; 20():347. PubMed ID: 32742194
[TBL] [Abstract][Full Text] [Related]
36. Insight into the structure, physiological function, and role in cancer of m6A readers-YTH domain-containing proteins.
Liao J; Wei Y; Liang J; Wen J; Chen X; Zhang B; Chu L
Cell Death Discov; 2022 Mar; 8(1):137. PubMed ID: 35351856
[TBL] [Abstract][Full Text] [Related]
37. The Potential Role of N6-Methyladenosine (m6A) Demethylase Fat Mass and Obesity-Associated Gene (FTO) in Human Cancers.
Wang JY; Chen LJ; Qiang P
Onco Targets Ther; 2020; 13():12845-12856. PubMed ID: 33364780
[TBL] [Abstract][Full Text] [Related]
38. METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST.
Yang X; Zhang S; He C; Xue P; Zhang L; He Z; Zang L; Feng B; Sun J; Zheng M
Mol Cancer; 2020 Feb; 19(1):46. PubMed ID: 32111213
[TBL] [Abstract][Full Text] [Related]
39. YTHDF2 exerts tumor-suppressor roles in gastric cancer via up-regulating PPP2CA independently of m
Zhou Y; Fan K; Dou N; Li L; Wang J; Chen J; Li Y; Gao Y
Biol Proced Online; 2023 Mar; 25(1):6. PubMed ID: 36870954
[TBL] [Abstract][Full Text] [Related]
40. The RNA m6A reader YTHDF2 controls NK cell antitumor and antiviral immunity.
Ma S; Yan J; Barr T; Zhang J; Chen Z; Wang LS; Sun JC; Chen J; Caligiuri MA; Yu J
J Exp Med; 2021 Aug; 218(8):. PubMed ID: 34160549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
